Hayat Pharmaceutical Industries Co (AMM:HPIC) EPS (Basic): JOD0.21 (TTM As of Mar. 2026)


AMM:HPIC Hayat Pharmaceutical Industries Co AMM:HPIC
79 GF Score
Price JOD3.12
GF Value JOD2.74
Valuation Modestly Overvalued
! 6 Warning Signs
View Full Analysis

What is Hayat Pharmaceutical Industries Co EPS (Basic)?

Hayat Pharmaceutical Industries Co AMM:HPIC 79 EPS (Basic) is JOD0.21 as of Mar. 2026. GuruFocus rates AMM:HPIC with a GF Score™ of 79/100 and a GF Value™ of JOD2.74 (Modestly Overvalued). The stock has 6 warning signs investors should review.

Hayat Pharmaceutical Industries Co's basic earnings per share (Basic EPS) for the three months ended in Mar. 2026 was JOD0.02. Its basic earnings per share (Basic EPS) for the trailing twelve months (TTM) ended in Mar. 2026 was JOD0.21.

Hayat Pharmaceutical Industries Co's EPS (Diluted) for the three months ended in Mar. 2026 was JOD0.02. Its EPS (Diluted) for the trailing twelve months (TTM) ended in Mar. 2026 was JOD0.21.

Hayat Pharmaceutical Industries Co's EPS without NRI for the three months ended in Mar. 2026 was JOD0.02. Its EPS without NRIearnings per share without non-recurring items for the trailing twelve months (TTM) ended in Mar. 2026 was 0.21.

During the past 12 months, Hayat Pharmaceutical Industries Co's average EPS without NRIGrowth Rate was -39.50% per year. During the past 3 years, the average EPS without NRI Growth Rate was -13.40% per year. During the past 5 years, the average EPS without NRI Growth Rate was -8.20% per year. During the past 10 years, the average EPS without NRI Growth Rate was 1.20% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the EPS without NRI Growth Rate using EPS without NRI data.

During the past 13 years, Hayat Pharmaceutical Industries Co's highest 3-Year average EPS without NRI Growth Rate was 57.30% per year. The lowest was -13.40% per year. And the median was 8.05% per year.

Hayat Pharmaceutical Industries Co  (AMM:HPIC) EPS (Basic) Explanation

EPS is the single most important variable used by Wall Street in determining the earnings power of a company. But investors need to be aware that Earnings per Share can be easily manipulated by adjusting depreciation and amortization rate or non-recurring items. That's why GuruFocus lists EPS without NRI, which better reflects the company's underlying performance.

Be Aware

Compared with Earnings per share, a company's cash flow is better indicator of the company's earnings power.

If a company's earnings per share is less than cash flow per share over long term, investors need to be cautious and find out why.

Hayat Pharmaceutical Industries Co EPS (Basic) Related Terms

Hayat Pharmaceutical Industries Co EPS (Basic) Historical Data

* Premium members only.

The historical data trend for Hayat Pharmaceutical Industries Co's EPS (Basic) can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Hayat Pharmaceutical Industries Co EPS (Basic) Chart

Hayat Pharmaceutical Industries Co Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
EPS (Basic)
Get a 7-Day Free Trial Premium Member Only Premium Member Only 0.38 0.37 0.25 0.33 0.24

Hayat Pharmaceutical Industries Co Quarterly Data
Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26
EPS (Basic) Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.05 0.04 0.06 0.09 0.02
AMM:HPIC
79GF Score
Hayat Pharmaceutical Industries Co AMM:HPIC
EPS (Basic) is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Hayat Pharmaceutical Industries Co EPS (Basic) Calculation

EPS (Basic) is a rough measurement of the amount of a company's profit that can be allocated to one share of its stock. Basic earnings per share (EPS) do not factor in the dilutive effects on convertible securities.

Hayat Pharmaceutical Industries Co's Basic EPS for the fiscal year that ended in Dec. 2025 is calculated as

Basic EPS (A: Dec. 2025 )=(Net Income-Preferred Dividends)/Shares Outstanding (Basic Average)
=(2.308-0)/9.500
=0.24

Hayat Pharmaceutical Industries Co's Basic EPS for the quarter that ended in Mar. 2026 is calculated as

Basic EPS (Q: Mar. 2026 )=(Net Income-Preferred Dividends)/Shares Outstanding (Basic Average)
=(0.153-0)/9.500
=0.02

EPS (Basic) for the trailing twelve months (TTM) ended in Mar. 2026 adds up the quarterly data reported by the company within the most recent 12 months, which was JOD0.21

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about EPS (Basic) →
What does a EPS (Basic) of JOD0.21 mean?
Hayat Pharmaceutical Industries Co (AMM:HPIC) has a EPS (Basic) of JOD0.21 as of Mar. 2026. Earnings per share (basic) equals net income divided by the standard, non-diluted average shares outstanding. View historical data on Hayat Pharmaceutical Industries Co and its competitors.
Is Hayat Pharmaceutical Industries Co's EPS (Basic) too high?
Hayat Pharmaceutical Industries Co's current EPS (Basic) is JOD0.21. Overall, Hayat Pharmaceutical Industries Co has a GF Score™ of 79/100 and is considered Modestly Overvalued, reflecting its overall financial health beyond just this single metric.
How does Hayat Pharmaceutical Industries Co's EPS (Basic) compare to ZTS and UTHR?
Hayat Pharmaceutical Industries Co's EPS (Basic) of JOD0.21 can be compared against companies in the Drug Manufacturers industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good EPS (Basic) for a Drug Manufacturers company?
A good EPS (Basic) depends on the Drug Manufacturers industry context. However, EPS (Basic) should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high EPS (Basic) mean?
A high EPS (Basic) can signal that a stock is expensive relative to its fundamentals. Earnings per share (basic) equals net income divided by the standard, non-diluted average shares outstanding. View historical data on Hayat Pharmaceutical Industries Co and its competitors. Hayat Pharmaceutical Industries Co's current EPS (Basic) is JOD0.21. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Hayat Pharmaceutical Industries Co stock overvalued right now?
Based on GuruFocus' analysis, Hayat Pharmaceutical Industries Co (AMM:HPIC) is currently considered Modestly Overvalued. The stock's GF Value™ is JOD2.74, compared to a current price of JOD3.12 — trading 13.9% above its estimated fair value. The current EPS (Basic) is JOD0.21. Hayat Pharmaceutical Industries Co's overall GF Score™ is 79/100 with 6 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is EPS (Basic) calculated?
EPS (Basic) is calculated from a company's financial statements. For Hayat Pharmaceutical Industries Co (AMM:HPIC), the current EPS (Basic) is JOD0.21 as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Hayat Pharmaceutical Industries Co (AMM:HPIC) Overvalued in 2026?

Based on GuruFocus' analysis, Hayat Pharmaceutical Industries Co stock appears to be overvalued. The current stock price of JOD3.12 is trading 13.9% above its estimated GF Value™ of JOD2.74. GuruFocus considers Hayat Pharmaceutical Industries Co to be Modestly Overvalued.

Key valuation signals for AMM:HPIC:

  • EPS (Basic): JOD0.21
  • GF Value™: JOD2.74 vs. price of JOD3.12 (13.9% above fair value)
  • GF Score™: 79/100 with 6 warning signs

No single metric tells the full story. See the AMM:HPIC stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Hayat Pharmaceutical Industries Co Business Description

Address Mohammed Ali Alkurdi St. Al-Rajeeb Amman, 1564 Amman, Amman, JOR, 11118
Hayat Pharmaceutical Industries Co is a Jordan based pharmaceutical manufacturing company. The princapal activity is producing human and veterinary medicines in all its forms and medical stickers and stockings, in addition to the production of medical supplies, body care lotions, cosmetics, sutures and initiating marketing campgains as well as import and export operations. Its products include Cardiovascular system, Infectious disease, Dermatology, Gastrointestinal system, Inner Ear & Balance, Men's Health, Neurology, Vitamins & Supplements, Women's Health, and Respiratory system. The operations business operating within one geographic sector which is the Hashemite Kingdom of Jordan.
79GF Score

Get the complete analysis for AMM:HPIC

EPS (Basic) is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

JOD3.12
Price
JOD2.74
GF Value